Compare Moderna, Inc. (MRNA) vs Riot Platforms Inc (RIOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Riot Platforms Inc — how do they compare? Moderna, Inc. trades at $220.99 (market cap $78.65B), while Riot Platforms Inc trades at $16.87 (market cap $6.32B). The key difference: Moderna, Inc. is far larger — about 12.4× Riot Platforms Inc's market cap, and Moderna, Inc. is trading nearer its 52-week high, Riot Platforms Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Moderna, Inc. for 59 Days and Riot Platforms Inc for 16 Days on average.
| MRNA | RIOT | |
|---|---|---|
Market Cap | $78.65B | $6.32B |
Volume | 37,373,437 | 30,571,756 |
Sector | Health | Financials |
52-Week High | $203.46 | $28.67 |
52-Week Low | $22.36 | $11.83 |
Typical Hold Time | 59 Days | 16 Days |
Enterprise Value | $74.80B | $6.73B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Moderna (MRNA) trades at $214.50, up 9.17% with strong technical momentum. The stock shows bullish moving average signals despite negative profitability metrics, with revenue declining from $18.9B in 2022 to $1.92B in 2025. Recent Nasdaq-100 inclusion creates institutional demand, though Citigroup downgraded to Sell citing valuation concerns after a 500% 2026 rally. The company continues beating EPS expectations despite net losses.
Outlook remains bifurcated between technical strength and fundamental challenges. The cancer vaccine pipeline offers growth potential, but persistent losses and high valuations create headwinds. Near-term momentum may continue from index fund inflows, though profitability concerns warrant caution for long-term investors.
RIOT stock trades at $16.95, down 8.58% over 24 hours, reflecting bearish technical signals despite a bullish analyst consensus. The company reported a net loss of $663.18 million in 2025, with negative profit margins and cash flow, but is pivoting to AI data center leasing with $9.8 billion in contracted revenue through 2048, per Seeking Alpha on 2026-10-01.
The outlook hinges on execution of the AI strategy, offering significant upside to the $31.64 consensus price target, but high execution risk and persistent losses pose threats to near-term shareholder value amid volatile market conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Riot Platforms Inc
Riot Platforms, Inc. is a Bitcoin mining company that focuses on building, operating, and expanding large-scale infrastructure for digital asset mining in North America. The company's operations include Bitcoin mining, data center hosting, and engineering solutions. Riot's strategy emphasizes vertical integration to maximize efficiency and scale its mining capacity, aiming to be a leader in the global Bitcoin and digital infrastructure industry.
Read more on RIOT →
